Top compounds associated with response to OR5H6


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
mRNA linifanib CTRPv2 pan-cancer AAC 0.071 0.04
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.04
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.07 0.04
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.05
mRNA etoposide CTRPv2 pan-cancer AAC 0.057 0.05
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.07 0.05
mRNA Doxorubicin gCSI pan-cancer AAC 0.096 0.05
mRNA decitabine CTRPv2 pan-cancer AAC -0.05 0.06
mRNA importazole CTRPv2 pan-cancer AAC -0.07 0.06
Download CSV